Type 17-specific immune pathways are active in early spondyloarthritis.
Hughes CD, Ryan SE, Steel KJA, van den Beukel MD, Trouw LA, van Schie KAJ, Toes REM, Menon B, Kirkham BW, Taams LS.
Hughes CD, et al. Among authors: kirkham bw.
RMD Open. 2023 Dec 20;9(4):e003328. doi: 10.1136/rmdopen-2023-003328.
RMD Open. 2023.
PMID: 38123480
Free PMC article.